FAM27E3, also known as FAM-interleukin-27 receptor subunit 3, is a potential drug target or biomarker associated with various diseases, including cancer, neurological disorders, and immune system disorders (Zhang et al., 2023; Gong et al., 2024; Zhou et al., 2022). This evidence concerns the gene FAM27E3 and immune system disorder.